193 related articles for article (PubMed ID: 15617996)
1. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.
Kölmel KF; Grange JM; Krone B; Mastrangelo G; Rossi CR; Henz BM; Seebacher C; Botev IN; Niin M; Lambert D; Shafir R; Kokoschka EM; Kleeberg UR; Gefeller O; Pfahlberg A
Eur J Cancer; 2005 Jan; 41(1):118-25. PubMed ID: 15617996
[TBL] [Abstract][Full Text] [Related]
2. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.
Krone B; Kölmel KF; Henz BM; Grange JM
Eur J Cancer; 2005 Jan; 41(1):104-17. PubMed ID: 15617995
[TBL] [Abstract][Full Text] [Related]
3. Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?
Tarhini AA; Land S; Gupta A; Kirkwood JM
Nat Clin Pract Oncol; 2005 May; 2(5):240-1. PubMed ID: 16264957
[No Abstract] [Full Text] [Related]
4. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C
J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577
[TBL] [Abstract][Full Text] [Related]
5. Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years.
Rieckmann A; Meyle KD; Rod NH; Baker JL; Benn CS; Aaby P; Sørup S
Vaccine; 2019 Oct; 37(44):6730-6736. PubMed ID: 31537447
[TBL] [Abstract][Full Text] [Related]
6. [Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].
Doré JF; Portoukalian J; Berthier-Vergnes O; Jacubovich R; Genève J; Bailly M; Lefthériotis E; Weissbrod A; Mayer M
Bull Cancer; 1990; 77(9):881-91. PubMed ID: 2224160
[TBL] [Abstract][Full Text] [Related]
7. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Búcar S; Salinas D; Orsola I
Eur Urol; 2005 Aug; 48(2):231-8; discussion 238. PubMed ID: 15963635
[TBL] [Abstract][Full Text] [Related]
8. The long-term clinical course of patients with cutaneous melanoma.
Gamel JW; George SL; Edwards MJ; Seigler HF
Cancer; 2002 Sep; 95(6):1286-93. PubMed ID: 12216097
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau.
Aaby P; Gustafson P; Roth A; Rodrigues A; Fernandes M; Sodemann M; Holmgren B; Benn CS; Garly ML; Lisse IM; Jensen H
Vaccine; 2006 Jul; 24(29-30):5718-25. PubMed ID: 16720061
[TBL] [Abstract][Full Text] [Related]
10. Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy.
Fortes C; Mastroeni S; Sera F; Concolino F; Abeni D; Melchi F; Forastiere F; Pasquini P
Eur J Cancer Prev; 2006 Apr; 15(2):171-7. PubMed ID: 16523015
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
13. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
15. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
16. Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study.
Krone B; Kölmel KF; Grange JM; Mastrangelo G; Henz BM; Botev IN; Niin M; Seebacher C; Lambert D; Shafir R; Kokoschka EM; Kleeberg UR; Gefeller O; Pfahlberg A
Eur J Cancer; 2003 Nov; 39(16):2372-8. PubMed ID: 14556930
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F
J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
19. Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
Adamina M; Weber WP; Rosenthal R; Schumacher R; Zajac P; Guller U; Frey DM; Oertli D; Zuber M; Heberer M; Spagnoli GC
Contemp Clin Trials; 2008 Mar; 29(2):165-81. PubMed ID: 17707139
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
